A Study to Find Out the Best Treatment for Walled-off Pancreatic Necrosis
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 14-001390
NCT ID: NCT02564965
Sponsor Protocol Number: 14-001390
About this study
The purpose of this study is to gather information on the best technique to manage necrotic (decaying) tissue of the pancreas between two acceptable endoscopic choices currently being used.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Adult (> 18 yo) patients
- With symptomatic walled- off pancreatic necrosis in which an endoscopic approach is appropriate based on cross-sectional imaging
- Must have solid necrotic material present in their pancreatic fluid collection as determined by MRI, EUS, or direct transluminal endoscopic imaging of the collection
Exclusion Criteria
- Previous intervention for pancreatic necrosis (surgical, percutaneous, or endoscopic)
- Indication for emergency laparotomy (compartment syndrome, bowel ischemia, bleeding, or perforation of a GI lumen)
- Uncorrectable coagulopathy.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Barham Abu Dayyeh, M.D., M.P.H. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available